Zaltidine

Zaltidine

SCHEMBL10340281

Br.Cc1nc(-c2csc(NC(=N)N)n2)c[nH]1

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Zaltidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ATP4A P20648 11/20 0.38
ATP4B P51164 11/20 0.38
ABL1 P00519 3/20 0.36
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
NPC1 O15118 1/20 0.34
GAA P10253 1/20 0.34
ALDH1A1 P00352 1/20 0.34
ALOX15 P16050 1/20 0.34
MAPK1 P28482 1/20 0.34
HSD17B10 Q99714 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PLAU P00749 1/20 0.34
XIAP P98170 1/20 0.34
GSTO1 P78417 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Zaltidine SCHEMBL10340389 1.00 ATP4A (0.38) ATP4AATP4BABL1MEN1KMT2A
Zaltidine SCHEMBL3605309 0.99 ATP4A (0.39) ATP4AATP4BABL1MEN1KMT2A
Zaltidine SCHEMBL9371241 0.97 ATP4A (0.38) ATP4AATP4BABL1MEN1KMT2A
SCHEMBL10859494 0.83 ATP4A (0.35) ATP4AATP4BABL1MEN1KMT2A
Hydrochloric Acid SCHEMBL10972462 0.82 MAPT (0.36) ATP4AATP4BABL1MEN1KMT2A
Hydrochloric Acid SCHEMBL10978743 0.82 MAPT (0.36) ATP4AATP4BABL1MEN1KMT2A
Bromide SCHEMBL10859506 0.81 ATP4A (0.35) ATP4AATP4BABL1
SCHEMBL10858261 0.80 ATP4A (0.35) ATP4AATP4BABL1
Hydrochloric Acid SCHEMBL11032190 0.78 ATP4A (0.38) ATP4AATP4BABL1MEN1KMT2A
Hydrochloric Acid SCHEMBL10974350 0.78 TYR (0.36) ATP4AATP4BABL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0178121-B1 IMPROVED FORMULATION OF ANTIINFLAMMATORY DRUGS PFIZER INC. (US) 1990-06-13 EP disclosed
EP-0178822-B1 2-GUANIDINO-4-(2-METHYL-4-IMIDAZOLYL)THIAZOLES IN THE TREATMENT OF RHEUMATOID ARTHRITIS PFIZER INC. (US) 1990-01-17 EP disclosed
US-4636498-A OXICAMS, ANTIULCER, ANTISECRETORY 2-GUANIDINO-4-(4-IMIDAZOLYL) THIAZOLES PFIZER INC. (US) 1987-01-13 US disclosed
US-4632993-A Process for making 2-guanidino-4-(2-methyl-4-imidazolyl) thiazole dihydrobromide PFIZER INC. (US) 1986-12-30 US disclosed
US-4591595-A 2-guanidino-4-(2-methyl-4-imidazolyl)thiazoles in the treatment of rheumatoid arthritis PFIZER INC. (US) 1986-05-27 US disclosed
US-4590299-A 2-guanidino-4-heteroarylthiazoles PFIZER INC. (US) 1986-05-20 US disclosed
EP-0178822-A2 2-Guanidino-4-(2-methyl-4-imidazolyl)thiazoles in the treatment of rheumatoid arthritis PFIZER INC. (US) 1986-04-23 EP disclosed
EP-0178123-A2 2-Guanidino-4-(2-methyl-4-imidazolyl)thiazole dihydrobromide and process therefor PFIZER INC. (US) 1986-04-16 EP disclosed
US-4510313-A 2-Guanidino-4-heteroarylthiazoles PFIZER INC. (US) 1985-04-09 US disclosed
EP-0050458-B1 2-GUANIDINO-4-HETEROARYLTHIAZOLES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM PFIZER INC. (US) 1985-01-02 EP disclosed
US-4452987-A Haloacetyl imidazoles PFIZER INC. (US) 1984-06-05 US disclosed
US-4374843-A 2-Guanidino-4-heteroarylthiazoles PFIZER INC. (US) 1983-02-22 US disclosed
EP-0050458-A2 2-Guanidino-4-heteroarylthiazoles and pharmaceutical compositions containing them PFIZER INC. (US) 1982-04-28 EP disclosed